AI assistant
Sending…
CONMED Corp — Director's Dealing 2011
May 18, 2011
31971_dirs_2011-05-18_566b8837-10bb-42ce-9d9b-f842df59e289.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2011-05-16
Reporting Person: TRYNISKI MARK E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-16 | Common Stock | M | 200 | — | Acquired | 3400 | Direct |
| 2011-05-18 | Common Stock | M | 200 | — | Acquired | 3600 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-16 | Rsus (restricted Stock Units) | $0 | M | 200 | Disposed | 2018-05-16 | Common Stock (200) | Direct |
| 2011-05-18 | Rsus (restricted Stock Units) | $0 | M | 200 | Disposed | 2017-05-18 | Common Stock (200) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7